![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Neovasc Inc. Richmond Ca, based in Canada, is a pharmaceutical company.
One of their significant offerings is Bovine pericardium, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2008-116 - Rev 02
This TSE Type CEP, issued on January 21, 2019, remains in force until December 11, 2023, ensuring its reliability within the pharmaceutical industry.